Changes in Plasma Growth Differentiation Factor-15 After Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients: A Prospective Study

References

• Abushouk AI, El-Husseny MWA, Bahbah EI, et al. Peroxisome proliferator-activated receptors as therapeutic targets for heart failure. Biomed Pharmacother. 2017;95:692–700. doi:10.1016/j.biopha.2017.08.083
   PubMed Web of Science ®Google Scholar
• Pucci G, Alcidi R, Tap L, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42. doi:10.1016/j.phrs.2017.03.008
   PubMed Web of Science ®Google Scholar
• Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330–9337. doi:10.3748/wjg.v20.i28.9330
   PubMed Web of Science ®Google Scholar
• Bennett JMH, Mehta S, Rhodes M. Surgery for morbid obesity. Postgrad Med J. 2007;83(975):8–15. doi:10.1136/pgmj.2006.048868
   PubMed Web of Science ®Google Scholar
• Dall’Asta C, Paganelli M, Morabito A, et al. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity. 2010;18(4):854–857. doi:10.1038/oby.2009.320
   PubMed Web of Science ®Google Scholar
• Syu Y, Inui A, Chen C. A perspective on metabolic surgery from a gastroenterologist. J Pharmacol Sci. 2017;133(2):61–64. doi:10.1016/j.jphs.2017.01.001
   PubMed Web of Science ®Google Scholar
• Lee WJ, Owaid Almalki O. Recent advancements in bariatric/metabolic surgery. Ann Gastroenterol Surg. 2017;1(3):171–179. doi:10.1002/ags3.12030
   PubMed Web of Science ®Google Scholar
• Gentileschi P. Laparoscopic sleeve gastrectomy as a primary operation for morbid obesity: experience with 200 patients. Gastroenterol Res Pract. 2012;2012:1–4. doi:10.1155/2012/801325
   Web of Science ®Google Scholar
• Fuks D, Verhaeghe P, Brehant O, et al. Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery. 2009;145(1):106–113. doi:10.1016/j.surg.2008.07.013
   PubMed Web of Science ®Google Scholar
• Lombardo V, Baratta R, Giannone G. Laparoscopic sleeve gastrectomy for morbid obesity. Our initial experience. Ann Ital Chir. 2010;81(1):17–20.
   PubMed Web of Science ®Google Scholar
• Rosenthal RJ. International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19. doi:10.1016/j.soard.2011.10.019
   PubMed Web of Science ®Google Scholar
• Emadeldin D, Ramadan A, Fala SY, et al. Disease modifying efficacy of memantine in Alzheimer’s disease; a pooled analysis of 13 randomized controlled trials. J Neurol Sci. 2017;381:767. doi:10.1016/j.jns.2017.08.2166
   Web of Science ®Google Scholar
• Wu W, Lee W, Lee T, Chen S, Chen C. Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, −7, and −9 among patients with type 2 diabetes mellitus? World J Diabetes. 2020;11(6):252–260. doi:10.4239/wjd.v11.i6.252
   PubMed Web of Science ®Google Scholar
• Wang Y, Song Y, Chen J, et al. Roux-en-Y gastric bypass versus sleeve gastrectomy for super super obese and super obese: systematic review and meta-analysis of weight results, comorbidity resolution. Obes Surg. 2019;29(6):1954–1964. doi:10.1007/s11695-019-03817-4
   PubMed Web of Science ®Google Scholar
• Lerner L, Hayes TG, Tao N, et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle. 2015;6(4):317–324. doi:10.1002/jcsm.12033
   PubMed Web of Science ®Google Scholar
• Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock. 2005;23(6):543–548.
   PubMed Web of Science ®Google Scholar
• Brown DA, Lindmark F, Stattin P, et al. Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res. 2009;15(21):6658–6664. doi:10.1158/1078-0432.CCR-08-3126
   PubMed Web of Science ®Google Scholar
• Meyer-Siegler KL, Bellino MA, Tannenbaum M. Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer. 2002;94(5):1449–1456. doi:10.1002/cncr.10354
   PubMed Web of Science ®Google Scholar
• Johnen H, Lin S, Kuffner T, et al. Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1. Nat Med. 2007;13(11):1333–1340. doi:10.1038/nm1677
   PubMed Web of Science ®Google Scholar
• Schopfer DW, Ku IA, Regan M, et al. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). Am Heart J. 2014;167(2):186–192.e1. doi:10.1016/j.ahj.2013.09.013
   PubMed Web of Science ®Google Scholar
• Kempf T, Guba-Quint A, Torgerson J, et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol. 2012;167(5):671–678. doi:10.1530/EJE-12-0466
   PubMed Web of Science ®Google Scholar
• Vila G, Riedl M, Anderwald C, et al. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem. 2011;57(2):309–316. doi:10.1373/clinchem.2010.153726
   PubMed Web of Science ®Google Scholar
• Park JY, Yoonseok Heo Y, Kim YJ, et al. Long-term effect of bariatric surgery versus conventional therapy in obese Korean patients: a multicenter retrospective cohort study. Ann Surg Treat Res. 2019;96(6):283–289. doi:10.4174/astr.2019.96.6.283
   PubMed Web of Science ®Google Scholar
• Fairlie WD, Moore AG, Bauskin AR, et al. MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation. J Leukoc Biol. 1999;65(1):2–5. doi:10.1002/jlb.65.1.2
   PubMed Web of Science ®Google Scholar
• Lind L, Wallentin L, Kempf T, et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Eur Heart J. 2009;30(19):2346–2353. doi:10.1093/eurheartj/ehp261
   PubMed Web of Science ®Google Scholar
• Wakchoure S, Swain TM, Hentunen TA, et al. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate. 2009;69(6):652–661. doi:10.1002/pros.20913
   PubMed Web of Science ®Google Scholar
• Hsu JY, Crawley S, Chen M, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550(7675):255–259. doi:10.1038/nature24042
   PubMed Web of Science ®Google Scholar
• Dolo PR, Yao L, Liu PP, et al. Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human. Am J Surg. 2020;220(3):725–730. doi:10.1016/j.amjsurg.2020.01.041
   PubMed Web of Science ®Google Scholar
• Kleinert M, Bojsen-Møller KN, Jørgensen NB, et al. Effect of bariatric surgery on plasma GDF15 in humans. Am J Physiol Metab. 2019;316:E615–E621.
   PubMed Web of Science ®Google Scholar
• Patel S, Alvarez-Guaita A, Melvin A, et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 2019;29(3):707–718.e8. doi:10.1016/j.cmet.2018.12.016
   PubMed Web of Science ®Google Scholar